These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1119 related items for PubMed ID: 15642767

  • 1. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 2. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M, Shimizu H, Murakami T, Enosawa S, Suzuki C, Takeno Y, Hakamata Y, Kudou S, Izawa S, Yasue T, Kobayashi E.
    Transplant Proc; 2005 Jan 18; 37(1):143-5. PubMed ID: 15808575
    [Abstract] [Full Text] [Related]

  • 3. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K.
    J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152
    [Abstract] [Full Text] [Related]

  • 4. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.
    Fujishiro J, Kudou S, Iwai S, Takahashi M, Hakamata Y, Kinoshita M, Iwanami S, Izawa S, Yasue T, Hashizume K, Murakami T, Kobayashi E.
    Transplantation; 2006 Sep 27; 82(6):804-12. PubMed ID: 17006328
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model.
    Suzuki C, Takahashi M, Morimoto H, Izawa A, Ise H, Fujishiro J, Murakami T, Ishiyama J, Nakada A, Nakayama J, Shimada K, Ikeda U, Kobayashi E.
    J Heart Lung Transplant; 2006 Mar 27; 25(3):302-9. PubMed ID: 16507424
    [Abstract] [Full Text] [Related]

  • 6. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.
    Chiba K, Hoshino Y, Suzuki C, Masubuchi Y, Yanagawa Y, Ohtsuki M, Sasaki S, Fujita T.
    Transplant Proc; 1996 Apr 27; 28(2):1056-9. PubMed ID: 8623225
    [No Abstract] [Full Text] [Related]

  • 7. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 8. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transpl Immunol; 2001 Feb 15; 8(4):267-77. PubMed ID: 11316070
    [Abstract] [Full Text] [Related]

  • 9. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov 15; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

  • 10. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K.
    Transplant Proc; 1996 Apr 15; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 15; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 12. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J, Suzuki C, Kudou S, Yasue T, Hakamata Y, Takahashi M, Murakami T, Hashizume K, Kobayashi E.
    J Heart Lung Transplant; 2006 Jul 15; 25(7):825-33. PubMed ID: 16818126
    [Abstract] [Full Text] [Related]

  • 13. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH, Milekhin V, Zhang H, Huang HZ.
    Acta Pharmacol Sin; 2003 Sep 15; 24(9):847-52. PubMed ID: 12956930
    [Abstract] [Full Text] [Related]

  • 14. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Chen Y, Liu Y, Yuan Z, Tian L, Dallman MJ, Thompson PW, Tam PK, Lamb JR.
    Transplantation; 2007 Jun 27; 83(12):1602-10. PubMed ID: 17589344
    [Abstract] [Full Text] [Related]

  • 15. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY, Tokita D, Wang Z, Wang HC, Zhan J, Brinkmann V, Thomson AW.
    Transpl Immunol; 2008 Nov 27; 20(1-2):88-94. PubMed ID: 18694829
    [Abstract] [Full Text] [Related]

  • 16. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y.
    J Immunol; 1998 May 15; 160(10):5037-44. PubMed ID: 9590253
    [Abstract] [Full Text] [Related]

  • 17. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1911-8. PubMed ID: 17161344
    [Abstract] [Full Text] [Related]

  • 18. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
    del Rio ML, Pabst O, Ramirez P, Penuelas-Rivas G, Förster R, Rodriguez-Barbosa JI.
    Transpl Int; 2007 Oct 20; 20(10):895-903. PubMed ID: 17854447
    [Abstract] [Full Text] [Related]

  • 19. Protosappanin a, an immunosuppressive constituent from a Chinese herb, prolongs graft survival and attenuates acute rejection in rat heart allografts.
    Wu J, Hou JB, Zhang MM, Zou YP, Yu B.
    Transplant Proc; 2008 Dec 20; 40(10):3719-22. PubMed ID: 19100473
    [Abstract] [Full Text] [Related]

  • 20. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F, Fisniku O, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K, Kobayashi M, Benediktsson H, Jiang H.
    Transplant Proc; 2005 Dec 20; 37(1):134-6. PubMed ID: 15808572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.